PopVax is an Indian full-stack biotechnology company developing novel mRNA vaccines and therapeutics using computational protein design. Our first vaccine is a next-generation COVID-19 booster, which will enter a first-in-human Phase I clinical trial in the U.S. early this year. This vaccine is intended to broaden protection against both current and predicted future SARS-CoV-2 variants, reducing the possibility of a current mutation in the virus suddenly causing another massive wave of infection. We have a preclinical pipeline of 6 additional novel vaccine candidates built on our mRNA-LNP platform that we will be taking into clinical trials over the next few years. Our work to date has been funded primarily via project agreements totalling 10+ million USD with the Bill & Melinda Gates Foundation and Vitalik Buterin's public health & biosecurity organisation Balvi.
We have seen up close that there are incredible capabilities in vaccine design, testing,
and optimization just waiting to be unlocked that will enable us to pursue and perhaps even succeed at realizing wildly ambitious agendas such as ending TB, preventing future pandemics via broadly-protective vaccines, tackling the deadly scourge of antimicrobial resistance, eliminating debilitating degenerative diseases like multiple sclerosis, and curing fiendishly tricky chronic conditions such as ME/CFS and Long COVID. We are initiating multiple new vaccine programs this year to go after a number of these opportunities.
We are seeking an Senior Executive - QC (Analytical - LCMS) to join our team in Hyderabad (note: in-person only; we do not offer remote work) to play a key role in helping develop, optimize, and document analytical protocols and assays for our mRNA-LNP vaccines and therapeutics.
Candidates Must Have
MS in Analytical Chemistry, Biochemistry, or a related field with a minimum of 3 years of experience in analytical method development, preferably related to biologics.
Hands-on experience of chromatograph